Filing Details
- Accession Number:
- 0001415889-24-027557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-22 17:45:42
- Reporting Period:
- 2024-11-21
- Accepted Time:
- 2024-11-22 17:45:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419041 | Forte Biosciences Inc. | FBRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339375 | A Antony Riley | C/O Forte Biosciences, Inc. 3060 Pegasus Park Dr., Bldg 6 Dallas TX 75247 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-21 | 22,514 | $5.55 | 30,776 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On November 19, 2024, the Issuer and the Reporting Person entered into a Securities Purchase Agreement (the "SPA"), pursuant to which the Reporting Person purchased 22,514 shares of common stock from the Issuer in a private placement in reliance upon the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. The transaction contemplated by the SPA closed on November 21, 2024.
Billionaire Hedge Funds
